Galliprant is indication for the treatment of pain associated with mild to moderate osteoarthritis in dogs.
Important Safety Information
Name of the veterinary medicinal product: Galliprant 20 mg, 60 mg, and 100 mg tablets for dogs. Indication: Galliprant is indicated for the treatment of pain associated with mild to moderate osteoarthritis in dogs. Side effects, precautions, warnings and contraindications: Refer to the product packaging and leaflets for information about side effects, precautions, warnings and contraindications. Storage: Do not store above 30°C. Any half tablets should be stored in the bottle. In order to avoid any accidental ingestion, store tablets out of reach of animals.
Galliprant contains grapiprant. Legal category POM-V (UK) POM (IE).
Further information is available from the Summary of Product Characteristics or datasheet. Information on this veterinary medicinal product is available on the website of the European Medicines Agency https://www.ema.europa.eu. For further information call Elanco Animal Health on +44(0)1256 353131 or write to: Elanco Animal Health, Lilly House, Priestley Road, Basingstoke, Hampshire RG24 9NL, United Kingdom.
Use medicines responsibly www.noah.co.uk/responsible (UK); www.apha.ie (IE).